Global Sales Force Automation Leader Expands in Australia
ATLANTA, July 23 /PRNewswire/ -- Glaxo Wellcome has awarded IMS HEALTH's
Sales Technology/Walsh unit a contract to support its Australian sales force
following a highly competitive bidding process. IMS HEALTH (NYSE: RX) is the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries.
Sales Technologies/Walsh's sales force automation product, Premiere(SM),
was selected after a thorough competitive analysis of seven companies,
including the incumbent vendor. The contract with Glaxo Wellcome, Australia's
second largest pharmaceutical company, will cover 200 sales force users.
"Our key reason for selecting Sales Technologies/Walsh over the other six
companies is its ability to integrate our sales and marketing teams, enabling
us to deliver superior customer service," said Tony Kayrooze, IS manager,
Glaxo Wellcome.
Added Ronald Brown, chief executive officer of IMS HEALTH's Sales
Technologies/Walsh: "We are delighted to be working with Glaxo Wellcome in
Australia, and are confident that the strengths of our localized support and
strategic technologies will lead to a successful and long-term business
partnership."
Sales Technologies/Walsh is the leading global provider of sales force
automation products and services to the pharmaceutical industry. More than
35,000 pharmaceutical executives worldwide depend on Sales Technologies/Walsh
to make business decisions each day. Services include sales force automation
systems, strategic sales and marketing information solutions, and the
provision of client-critical databases. Additional information is available
at http://www.salestech.com.
Sales Technologies/Walsh is a division of IMS HEALTH (NYSE: RX), the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries. With more than $1 billion in 1997 revenue, IMS HEALTH
operates in over 90 countries. IMS HEALTH is the largest pharmaceutical
manufacturer information partner, with over 40 years' experience in the
industry. Key products and services integral to customer day-to-day
operations include: market research for prescription and over-the-counter
pharmaceutical products; sales management information to optimize sales force
productivity; technology enabled selling solutions for sales and marketing
decision-making; and technology systems and information services that support
managed care organizations. Additional information is available at
http://imshealth.com.
SOURCE IMS Health
 back to top
Related links:
http://www.imshealth.com
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Mary Margaret Ray of IMS Health, 404-841-4148
|
